238 related articles for article (PubMed ID: 29673358)
1. Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression.
Zeng X; Guo R; Dong M; Zheng J; Lin H; Lu H
J Transl Med; 2018 Apr; 16(1):106. PubMed ID: 29673358
[TBL] [Abstract][Full Text] [Related]
2. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
3. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice.
Arnaud C; Poulain L; Lévy P; Dematteis M
Atherosclerosis; 2011 Dec; 219(2):425-31. PubMed ID: 21917260
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
5. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50.
Fang G; Song D; Ye X; Mao SZ; Liu G; Liu SF
Am J Pathol; 2012 Nov; 181(5):1530-9. PubMed ID: 22940439
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor-4-Mediated Inflammation is Involved in Intermittent Hypoxia-Induced Lung Injury.
Zou F; Su X; Pan P
Lung; 2020 Oct; 198(5):855-862. PubMed ID: 32785858
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
[TBL] [Abstract][Full Text] [Related]
8. TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.
Tang YL; Jiang JH; Wang S; Liu Z; Tang XQ; Peng J; Yang YZ; Gu HF
PLoS One; 2015; 10(4):e0123685. PubMed ID: 25860573
[TBL] [Abstract][Full Text] [Related]
9. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
10. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent inflammatory factor production and NFκB activation in a rodent model of intermittent hypoxia.
Li S; Qian XH; Zhou W; Zhang Y; Feng J; Wan NS; Zhang Z; Guo R; Chen BY
Swiss Med Wkly; 2011; 141():w13309. PubMed ID: 22143914
[TBL] [Abstract][Full Text] [Related]
12. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
[TBL] [Abstract][Full Text] [Related]
13. Ursolic Acid Attenuates Atherosclerosis in ApoE
Li Q; Zhao W; Zeng X; Hao Z
Molecules; 2018 May; 23(5):. PubMed ID: 29735887
[TBL] [Abstract][Full Text] [Related]
14. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.
Jun J; Reinke C; Bedja D; Berkowitz D; Bevans-Fonti S; Li J; Barouch LA; Gabrielson K; Polotsky VY
Atherosclerosis; 2010 Apr; 209(2):381-6. PubMed ID: 19897196
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.
Wang X; Chen Q; Pu H; Wei Q; Duan M; Zhang C; Jiang T; Shou X; Zhang J; Yang Y
Lipids Health Dis; 2016 Feb; 15():33. PubMed ID: 26965176
[TBL] [Abstract][Full Text] [Related]
16. Research on mechanism of PCS in damaging vascular endothelial cells and promoting formation of atherosclerosis via TLR4/TREM-1.
Zhang ZY; Hu CF; Wang MX; Lin J; Li JM; Wang RZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7533-7542. PubMed ID: 30468503
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia.
Poulain L; Richard V; Lévy P; Dematteis M; Arnaud C
Mediators Inflamm; 2015; 2015():620258. PubMed ID: 25873766
[TBL] [Abstract][Full Text] [Related]
18. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
[TBL] [Abstract][Full Text] [Related]
19. Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice.
Liu Z; Wang J; Huang X; Li Z; Liu P
Transl Res; 2016 Jun; 172():18-29.e2. PubMed ID: 26924042
[TBL] [Abstract][Full Text] [Related]
20. PSRC1 overexpression attenuates atherosclerosis progression in apoE
Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
